High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Rescue for Pediatric Brain Tumor Patients: A Single Institution Experience from UCLA

Background. Dose-dependent response makes certain pediatric brain tumors appropriate targets for high-dose chemotherapy with autologous hematopoietic stem-cell rescue (HDCT-AHSCR). Methods. The clinical outcomes and toxicities were analyzed retrospectively for 18 consecutive patients ≤19 y/o treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Panosyan, Eduard H., Ikeda, Alan K., Chang, Vivian Y., Laks, Dan R., Reeb, Charles L., Bowles, La Vette, Lasky, Joseph L., Moore, Theodore B.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087896/
https://www.ncbi.nlm.nih.gov/pubmed/21559259
http://dx.doi.org/10.1155/2011/740673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087896/
https://www.ncbi.nlm.nih.gov/pubmed/21559259
http://dx.doi.org/10.1155/2011/740673

Ejemplares similares